
CRWD · Nasdaq
The supplied consensus is Buy across 44 analysts. The only aggregate target provided is a mean of $189.38; high and low targets are unavailable, so the target distribution, clustering and spread cannot be established. BNK Invest separately cites a $194.03 average 12-month target, which the stock crossed at $202.54 before reaching $211.22. The supplied evidence does not identify the most bullish or least bullish analyst, nor does it document any rating or target revisions during the week. The substantive tension is between broad positive recommendations and the limited target evidence, with Zacks specifically warning that analyst optimism may make the consensus less informative.